02:39:59 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-14 Bokslutskommuniké 2024
2024-11-14 Kvartalsrapport 2024-Q3
2024-08-16 Kvartalsrapport 2024-Q2
2024-05-30 Årsstämma 2024
2024-05-17 Kvartalsrapport 2024-Q1
2024-03-01 X-dag ordinarie utdelning CSMED 0.00 DKK
2024-02-14 Bokslutskommuniké 2023
2023-12-15 X-dag ordinarie utdelning CSMED 0.00 DKK
2023-07-18 Kvartalsrapport 2023-Q3
2023-05-17 Kvartalsrapport 2023-Q2
2023-04-14 Extra Bolagsstämma 2023
2023-02-17 Kvartalsrapport 2023-Q1
2023-02-14 Årsstämma 2023
2023-02-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2022-11-18 Bokslutskommuniké 2022
2022-08-13 Kvartalsrapport 2022-Q3
2022-05-20 Kvartalsrapport 2022-Q2
2022-02-18 Kvartalsrapport 2022-Q1
2021-12-10 X-dag ordinarie utdelning CSMED 0.00 DKK
2021-12-09 Årsstämma 2022
2021-11-18 Bokslutskommuniké 2021

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriLäkemedel & Handel
CS Medica är ett danskt medicintekniskt bolag, dedikerat till läkemedelsforskning, utveckling, tillverkning och global kommersialisering. Bolaget blandar vetenskap och natur för att förbättra patienters liv med cannabinoidterapier för smärtlindring, och för att hantera autoimmuna och stressrelaterade symtom. Globalt erbjuder CS Medica CBD-behandlingar över disk (OTC), inklusive patenterade medicinska produkter, MHRA och MDR-registrerade artiklar, under varumärket CANNASEN® eller med egen märkning.
2024-02-14 18:52:52

The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of the Annual General Meeting that will be held on Thursday, February 29, 2024, at 15:00 CET, at Fruebjergvej 3, 2100 Copenhagen, Denmark.  Shareholders will be entitled to vote by submitting postal vote forms before the meeting. Information about the resolutions passed at the meeting will be made public on February 29, 2024, after the general meeting has been held.

Agenda
1.   Election of chairman of the meeting.
2.   Presentation of the annual report with auditors' report for adoption.
3.   Resolution concerning the appropriation of losses as recorded in the adopted annual report.
4.   Election of members to the board of directors.
5.   Election of the Company's auditor.
6.   Any other business

The total number of votes as of the date of this notice is 12,322,635.

2. Presentation of the annual report with auditors' report for adoption.
The annual report as approved by the board of directors will be presented to the general meeting for approval.

3. Resolution concerning the appropriation of losses as recorded in the adopted annual report.
The board of directors proposes that the result for the period 1 October 2022 - 30 September 2023 (DKK - 14.512.764) is carried forward to the following year.

4. Election of members to the board of directors.
The board members are proposed to be re-elected.

5. Election of auditor.
The board of directors proposes that the existing auditor (Christensen Kjærulff Statsautoriseret Revisionsaktieselskab) is re-elected.

Sign up for the Annual General Meeting
Send email to info@cs-medica.com

Registration
The registration date is 20 February 2024. Only those who are shareholders on this date have the right to participate and vote at the general meeting.

A shareholder has also the possibility of requesting an admission for a proxy holder who attends the general meeting on behalf of the shareholder. The request must be made, no later than 2 days before the general meeting, cf. section 5.9 of the articles of association. Such request must be made to e-mail info@cs-medica.com.The request must be received no later than 26 February 2024, at 11.59 PM (CET).  The shareholder must fill in and sign the proxy and postal voting form, which can be found on the Company's website www.cs-medica.com. The proxy must bring the admission card and the original form to the general meeting.

Participation
To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their names in the share register. Such registration must be duly affected in the share register on 20 February 2024, and the shareholders must therefore advise their nominees well in advance of such date.

The shareholders have the right to ask questions about the issues on the agenda to be discussed at the general meeting. The questions can be made in writing before the general meeting or at the general meeting. The answer will - with the limitations that follow from the legislation - if possible be made at the general meeting or be made available to the shareholders no later than two weeks after the general meeting.

All material mentioned in this notice can be obtained from Gitte Lund Henriksen, e-mail glh@cs-medica.com.The material will only be forwarded by e-mail, and thus the e-mail address must be specified.

CS MEDICA A/S

On behalf of the board of directors
Jørgen Flemming Ladefoged, Chairman